Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
The VaDDC Executive Committee is pleased to announce the next VirginiaRx meeting will be held at Virginia Tech in May 2019.
- The VaDDC strives to promote the vibrant drug discovery and development efforts at the research institutions in the state of Virginia.
- VirginiaDrugDiscoveryRx was a resounding success with 146 attendees from academia, the private sector and government. The meeting showcased the dynamic drug discovery environment in the state of Virginia and focused on the development of public-private drug discovery partnerships, which are foundational to translational research.
- The recently held VirginiaDrugDiscoveryRx was the 3rd annual meeting organized by the Virginia Drug Discovery Consortium, and followed the highly successful VirginiaBrainRx (2016, Virginia Commonwealth University, Richmond, VA) and VirginiaCancerRx (2017, University of Virginia, Charlottesville, VA).
Thank you to our sponsors whose participation in the recent VirginiaDrugDiscoveryRx Symposium held at George Mason University, June 25-26, 2018 was key to the meeting’s success.
Frank Gupton receives a $25M award from the Gates foundation for the "Medicines for All" Initiative" The Bill & Melinda Gates Foundation has awarded the Virginia Commonwealth University School of Engineering $25 million to create the Medicines for All Institute, a...read more
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...read more
Professor Rob Gourdie, Director of the Virginia Tech Carilion Research Institute’s (VTCRI) Center for Heart and Regenerative Medicine Research, previously founded First String Research Inc., which is poised to commercialize a treatment for debilitating foot ulcers in...read more
Want to work with us?
If you are interested in supporting this initiative, please contact us.